SG Americas Securities
BLTE

SG Americas Securities’s Belite Bio BLTE Stock Holding History

SG Americas Securities’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141K Sell
913
-1,231
-57% -$189K ﹤0.01% 2946
2026
Q1 		$342K Sell
2,144
-611
-22% -$103K ﹤0.01% 2387
2025
Q4 		$441K Buy
+2,755
New +$326K ﹤0.01% 2570

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SG Americas Securities's BLTE Position: Q2 2026 in Review

SG Americas Securities reduced its Belite Bio (BLTE) stake by 57% in Q2 2026, selling an estimated $189K and leaving 913 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

SG Americas Securities first reported a position in BLTE in Q4 2025 and has held it in 3 quarters since. The position peaked at $441K in Q4 2025. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • SG Americas Securities held 913 shares of Belite Bio worth $141K as of Q2 2026.
  • SG Americas Securities sold 1,231 Belite Bio shares in Q2 2026, an estimated $189K.
  • Belite Bio made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2946 holding.
  • SG Americas Securities first reported a position in Belite Bio in Q4 2025 and has held it in 3 quarters since.
  • SG Americas Securities's Belite Bio position peaked at $441K in Q4 2025.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.